MedTrace Logo

BIBR 1048 in the Prevention of Venous Thromboembolism in Patients Undergoing Primary Elective Total Hip Replacement Surgery

NCT02170701 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 289

Last updated 2018-08-31

No results posted yet for this study

Summary

* To determine the therapeutic window of BIBR 1048 in order to select doses for further studies in the development plan.
* Twice daily regimen will be tested for most dose levels and once daily administration will also be evaluated when appropriate.

Conditions

  • Venous Thromboembolism

Interventions

DRUG

BIBR 1048

Ascending doses (in mg) given twice daily

Sponsors & Collaborators

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-10-31
Primary Completion
2001-06-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02170701 on ClinicalTrials.gov